{"transactions":[{"id":4625406,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controllership"}}],"security":"Restricted Stock Unit","published_at":"2026-09-23T20:17:14.000Z","date":"2026-09-22","kind":"exercise","planned":false,"acquired":false,"shares":2223,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":9022,"derivative":{"underlying":"Common Stock","underlying_shares":2223},"source":{"system":"sec-edgar","filing":"0001927648-26-000005","document":"wk-form4_1790194631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1927648/000192764826000005/wk-form4_1790194631.xml","form_type":"4"}},{"id":4625405,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2026-09-23T20:17:14.000Z","date":"2026-09-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":768,"price":152.67,"value":117250.56,"ownership":{"direct":true},"balance_after":1455,"source":{"system":"sec-edgar","filing":"0001927648-26-000005","document":"wk-form4_1790194631.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1927648/000192764826000005/wk-form4_1790194631.xml","form_type":"4"}},{"id":4625404,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2026-09-23T20:17:14.000Z","date":"2026-09-22","kind":"exercise","planned":false,"acquired":true,"shares":2223,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":2223,"source":{"system":"sec-edgar","filing":"0001927648-26-000005","document":"wk-form4_1790194631.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1927648/000192764826000005/wk-form4_1790194631.xml","form_type":"4"}},{"id":311695,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controllership"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-03-12T20:37:46.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":5455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":5455,"derivative":{"exercise_price":148.56,"expiration_date":"2036-03-10","underlying":"Common Stock","underlying_shares":5455},"source":{"system":"sec-edgar","filing":"0001927648-26-000002","document":"wk-form4_1773347863.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000192764826000002/wk-form4_1773347863.xml","form_type":"4"}},{"id":311694,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controllership"}}],"security":"Restricted Stock Unit","published_at":"2026-03-12T20:37:46.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":2355,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":11245,"derivative":{"underlying":"Common Stock","underlying_shares":2355},"source":{"system":"sec-edgar","filing":"0001927648-26-000002","document":"wk-form4_1773347863.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000192764826000002/wk-form4_1773347863.xml","form_type":"4"}},{"id":318583,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controllership"}}],"security":"Restricted Stock Unit","published_at":"2025-09-23T23:55:57.000Z","date":"2025-09-22","kind":"grant","planned":false,"acquired":true,"shares":8890,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":8890,"derivative":{"underlying":"Common Stock","underlying_shares":8890},"source":{"system":"sec-edgar","filing":"0001927648-25-000009","document":"wk-form4_1758671755.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000192764825000009/wk-form4_1758671755.xml","form_type":"4"}},{"id":1140904,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-05-20T21:58:27.000Z","date":"2025-05-20","kind":"sale","planned":true,"acquired":false,"shares":1786,"price":59.31,"value":105927.66,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on November 26, 2024."}],"balance_after":14173,"source":{"system":"sec-edgar","filing":"0001048477-25-000060","document":"wk-form4_1747778300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000060/wk-form4_1747778300.xml","form_type":"4"}},{"id":1140903,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-05-20T21:58:27.000Z","date":"2025-05-19","kind":"tax_withholding","planned":true,"acquired":false,"shares":996,"price":59.27,"value":59032.92,"ownership":{"direct":true},"balance_after":15959,"source":{"system":"sec-edgar","filing":"0001048477-25-000060","document":"wk-form4_1747778300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000060/wk-form4_1747778300.xml","form_type":"4"}},{"id":1196017,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-03-20T23:38:48.000Z","date":"2025-03-19","kind":"sale","planned":true,"acquired":false,"shares":1295,"price":71.52,"value":92618.4,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on November 26, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person's direct holdings have been adjusted by two shares to correct a previous clerical error."}],"balance_after":16955,"source":{"system":"sec-edgar","filing":"0001048477-25-000041","document":"wk-form4_1742513921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000041/wk-form4_1742513921.xml","form_type":"4"}},{"id":1201352,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2025-03-18T23:53:01.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":9230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter."}],"balance_after":9230,"derivative":{"exercise_price":71.55,"exercise_date":"2026-03-17","expiration_date":"2035-03-16","underlying":"Common Stock","underlying_shares":9230},"source":{"system":"sec-edgar","filing":"0001048477-25-000039","document":"wk-form4_1742341974.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000039/wk-form4_1742341974.xml","form_type":"4"}},{"id":1201351,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-03-18T23:53:01.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":5970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 17, 2025. Price not applicable."}],"balance_after":18252,"source":{"system":"sec-edgar","filing":"0001048477-25-000039","document":"wk-form4_1742341974.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000039/wk-form4_1742341974.xml","form_type":"4"}},{"id":1201350,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-03-18T23:53:01.000Z","date":"2025-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":823,"price":69.44,"value":57149.12,"ownership":{"direct":true},"balance_after":12282,"source":{"system":"sec-edgar","filing":"0001048477-25-000039","document":"wk-form4_1742341974.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000039/wk-form4_1742341974.xml","form_type":"4"}},{"id":1247250,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-02-26T01:21:19.000Z","date":"2025-02-24","kind":"sale","planned":true,"acquired":false,"shares":1344,"price":68.38,"value":91902.72,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on November 26, 2024."}],"balance_after":13105,"source":{"system":"sec-edgar","filing":"0001048477-25-000009","document":"wk-form4_1740532872.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000009/wk-form4_1740532872.xml","form_type":"4"}},{"id":1432808,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-08-15T19:57:07.000Z","date":"2024-08-13","kind":"sale","planned":true,"acquired":false,"shares":714,"price":90,"value":64260.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on November 29, 2023."}],"balance_after":14449,"source":{"system":"sec-edgar","filing":"0001048477-24-000128","document":"wk-form4_1723751821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000128/wk-form4_1723751821.xml","form_type":"4"}},{"id":1509422,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-05-20T21:20:33.000Z","date":"2024-05-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":993,"price":76.97,"value":76431.21,"ownership":{"direct":true},"balance_after":15163,"source":{"system":"sec-edgar","filing":"0001048477-24-000084","document":"wk-form4_1716240012.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000084/wk-form4_1716240012.xml","form_type":"4"}},{"id":1542743,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-04-12T19:07:42.000Z","date":"2024-04-10","kind":"sale","planned":true,"acquired":false,"shares":2286,"price":90,"value":205740.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on November 29, 2023."}],"balance_after":16156,"source":{"system":"sec-edgar","filing":"0001048477-24-000061","document":"wk-form4_1712948853.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000061/wk-form4_1712948853.xml","form_type":"4"}},{"id":1570152,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-03-20T00:55:14.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":7050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 15, 2025 and 1/48th on the 15th day of each month thereafter."}],"balance_after":7050,"derivative":{"exercise_price":83.87,"exercise_date":"2025-03-15","expiration_date":"2034-03-14","underlying":"Common Stock","underlying_shares":7050},"source":{"system":"sec-edgar","filing":"0001048477-24-000050","document":"wk-form4_1710896100.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000050/wk-form4_1710896100.xml","form_type":"4"}},{"id":1570151,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-03-20T00:55:14.000Z","date":"2024-03-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":372,"price":83.87,"value":31199.64,"ownership":{"direct":true},"balance_after":18442,"source":{"system":"sec-edgar","filing":"0001048477-24-000050","document":"wk-form4_1710896100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000050/wk-form4_1710896100.xml","form_type":"4"}},{"id":1570150,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-03-20T00:55:14.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":4720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 15, 2024. Price not applicable."}],"balance_after":18814,"source":{"system":"sec-edgar","filing":"0001048477-24-000050","document":"wk-form4_1710896100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000050/wk-form4_1710896100.xml","form_type":"4"}},{"id":1887303,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-05-18T21:31:00.000Z","date":"2023-05-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":796,"price":92.02,"value":73247.92,"ownership":{"direct":true},"balance_after":14094,"source":{"system":"sec-edgar","filing":"0001209191-23-030736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123030736/doc4.xml","form_type":"4"}},{"id":1947999,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2023-03-18T01:26:24.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":5720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 15, 2024 and 1/48th on the 15th day of each month thereafter."}],"balance_after":5720,"derivative":{"exercise_price":87.74,"exercise_date":"2024-03-15","expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":5720},"source":{"system":"sec-edgar","filing":"0001567619-23-005287","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761923005287/doc1.xml","form_type":"4"}},{"id":1947998,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-03-18T01:26:24.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":3760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on March 15, 2023. Price not applicable."}],"balance_after":14890,"source":{"system":"sec-edgar","filing":"0001567619-23-005287","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761923005287/doc1.xml","form_type":"4"}},{"id":2266247,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2022-05-19T00:42:05.000Z","date":"2022-05-16","kind":"grant","acquired":true,"shares":17490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on May 16, 2023 and 1/48th on the 16th day of each month thereafter."}],"balance_after":17490,"derivative":{"exercise_price":77.32,"exercise_date":"2023-05-16","expiration_date":"2032-05-15","underlying":"Common Stock","underlying_shares":17490},"source":{"system":"sec-edgar","filing":"0001567619-22-011218","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922011218/doc1.xml","form_type":"4"}},{"id":2266246,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-05-19T00:42:05.000Z","date":"2022-05-16","kind":"grant","acquired":true,"shares":11130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 16, 2022. Price not applicable."}],"balance_after":11130,"source":{"system":"sec-edgar","filing":"0001567619-22-011218","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922011218/doc1.xml","form_type":"4"}}]}